Drugs News and Research

RSS

Combination regimen improves overall survival in acute myeloid leukemia patients

A combination regimen of venetoclax and azacitidine was safe and improved overall survival (OS) over azacitidine alone in certain patients with acute myeloid leukemia (AML), according to the Phase III VIALE-A trial led by The University of Texas MD Anderson Cancer Center.

13 Aug 2020

Study reveals key biochemical processes that advance understanding of colorectal cancer

A new insight into cell signals that control cancer growth and migration could help in the search for effective anti-cancer drugs. A McGill-led study reveals key biochemical processes that advance our understanding of colorectal cancer, the third most common cancer among Canadians.

13 Aug 2020

Exercise induces changes in sweat biomolecule levels, shows study

A new study shows that in addition to blood, endurance exercise induces changes in sweat biomolecule levels. These findings lay the groundwork for the development of future noninvasive exercise monitoring systems that utilize sweat as a biomarker source.

13 Aug 2020

Researchers develop new drugs to eradicate parasitic worms

In this breakthrough method, parasitic worms are prevented from using alternative metabolism routes offered by microbes living inside them.

12 Aug 2020

Researchers use genome editing to facilitate drug discovery based on natural fungus

Rice University scientists have won federal support for their pursuit of novel drugs to treat human disease.

11 Aug 2020

Study may reduce transmissible cancer in Tasmanian devils, offers hope for treating human cancers

A rare, transmissible tumor has brought the iconic Tasmanian devil to the brink of extinction, but new research by scientists at Washington State University and the Fred Hutchinson Cancer Research Center in Seattle indicates hope for the animals' survival and possibly new treatment for human cancers.

10 Aug 2020

Surgical delays did not impact overall survival in patients with early stage breast cancer

Beginning in March, as COVID-19 cases surged in various states in the U.S., the COVID-19 Pandemic Breast Cancer Consortium released recommendations that operations for ductal carcinoma in situ (DCIS) be deferred due to the pandemic.

10 Aug 2020

Researchers are developing therapeutic treatments for acute stroke

Every year in the United States, about 800,000 people experience a stroke. Many are left with neurological complications such as paralysis on one side of the body, speech and language problems, vision issues, behavioral changes, and memory loss.

10 Aug 2020

Genetic analysis reveals the inhibitory role of NSD2 enzyme in cellular senescence

Using a detailed genetic analysis, a research team from Japan-based Kumamoto University has discovered that the NSD2 enzyme, which controls the actions of several genes, also functions to block the aging of cells.

10 Aug 2020

Test pinpoints which people with gonorrhea can be treated with ciprofloxacin

A test designed by UCLA researchers can pinpoint which people with gonorrhea will respond successfully to the inexpensive oral antibiotic ciprofloxacin, which had previously been sidelined over concerns the bacterium that causes the infection was becoming resistant to it.

10 Aug 2020

COVID-19 patients have higher incidence of abnormal liver tests

Researchers at the Yale Liver Center found that patients with COVID-19 presented with abnormal liver tests at much higher rates than suggested by earlier studies.

10 Aug 2020

Study indicates a powerful treatment for pulmonary fibrosis

A pre-clinical study led by scientists at Cincinnati Children's demonstrates that in mice the drug barasertib reverses the activation of fibroblasts that cause dangerous scar tissue to build up in the lungs of people with idiopathic pulmonary fibrosis (IPF).

7 Aug 2020

Study may point to new therapeutic options for COVID-19

Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

7 Aug 2020

Synthetic peptide makes multidrug-resistant bacteria sensitive to antibiotics

Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a synthetic peptide that can make multidrug-resistant bacteria sensitive to antibiotics again when used together with traditional antibiotics, offering hope for the prospect of a combination treatment strategy to tackle certain antibiotic-tolerant infections.

7 Aug 2020

Drugs News and Research

Combination regimen improves overall survival in acute myeloid leukemia patients

Study reveals key biochemical processes that advance understanding of colorectal cancer

Exercise induces changes in sweat biomolecule levels, shows study

Researchers develop new drugs to eradicate parasitic worms

Researchers use genome editing to facilitate drug discovery based on natural fungus

Study may reduce transmissible cancer in Tasmanian devils, offers hope for treating human cancers

Surgical delays did not impact overall survival in patients with early stage breast cancer

Researchers are developing therapeutic treatments for acute stroke

Genetic analysis reveals the inhibitory role of NSD2 enzyme in cellular senescence

Test pinpoints which people with gonorrhea can be treated with ciprofloxacin

COVID-19 patients have higher incidence of abnormal liver tests

Study indicates a powerful treatment for pulmonary fibrosis

Study may point to new therapeutic options for COVID-19

Synthetic peptide makes multidrug-resistant bacteria sensitive to antibiotics

Researchers identify receptor responsible for activating energy-burning property of brown fat

Enhancing Breast Cancer Therapy through Killing ‘Sleeper Cells’

Researchers develop new models to study molecular characteristics of lung and pancreatic cancers

Newly discovered 'mutation fog' linked to normal DNA repair process

A New Way of Killing Tuberculosis

Researchers develop scalable strategy to find novel molecular glue degraders

Analytical Chemistry - Industry Focus eBook eBook

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics